A randomized trial comparing the efficacy on myocardial infarct size reduction of early vs. late abciximab administration during primary percutaneous coronary angioplasty.

Trial Profile

A randomized trial comparing the efficacy on myocardial infarct size reduction of early vs. late abciximab administration during primary percutaneous coronary angioplasty.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Mar 2012

At a glance

  • Drugs Abciximab (Primary)
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2012 Results published in the International Journal of Cardiology.
    • 13 Nov 2011 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 10 Feb 2009 Status changed from recruiting to completed, as reported by clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top